ADA2 p.Cys13Ter
c.39C>A · rs2517361483 · VCV2780451
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Consequence | nonsense (stop-gain) | predicted loss-of-function; NMD-escape possible for C-terminal truncations |
|---|---|---|
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Pangolin | Δ0.20 | gain · loss 0.00 · not in the SpliceAI release · independent |
| Constraint at this position | ||
| Conservation | phyloP 0.17 | GERP 0.52 |
| Overall | ||
| CADD | 27.2 | PHRED · no single calibrated threshold — expert panels disagree |
Predicted loss-of-function is descriptive, not an applied PVS1 code.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ADA2
- Protein
- p.Cys13Ter
- Coding
- c.39C>A
- MANE Select
- NM_001166105 · reported on NM_001282225
- dbSNP
- rs2517361483
- Type
- single nucleotide variant
- Location
- chr22:17209639 (GRCh38)
- Structure
- AlphaFold pLDDT 85.04 · 1 PDB
Disease context
deficiency of adenosine deaminase 2 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Deficiency of adenosine deaminase 2 (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Childhood, Infancy
- Prevalence
- <1 / 1 000 000 (Worldwide)
Similar variants
- ADA2 c.754-2A>G Likely pathogenic ★★ same condition
- ADA2 c.882-2A>G Pathogenic ★★ same condition
- ADA2 c.973-2A>G Pathogenic ★★ same condition
- ADA2 p.Arg169Gln Pathogenic/Likely pathogenic ★★ ⚠ same condition
- ADA2 p.Arg169Trp Pathogenic/Likely pathogenic ★★ same condition
- ADA2 p.Arg306Ter Likely pathogenic ★★ same condition
- ADA2 p.Arg312Ter Pathogenic ★★ same condition
- ADA2 p.Asn370Lys Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ada2-p-cys13ter (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown